BJDX

NASDAQ 已收盘

Bluejay Diagnostics, Inc.

1.00 USD
+0.08+6.12%
盘后 0.95 +0.82%
2026-08-03
市值
$1.03M
市盈率
EPS
-10.45
股息率
52 周区间
0.83 – 16.68
成交量
23.37M
Beta
0.88
目标价
52W 低 0.8352W 高 16.68
价格走势

公司简介

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critica...